Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Leucine-Rich Alpha-2-Glycoprotein 1 Promotes Metastatic Colorectal Cancer Growth Through Human Epidermal Growth Factor Receptor 3 Signaling.

Autor: Rathore M; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Curry K; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Huang W; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio., Wright M; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Martin D; Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio., Baek J; Department of Electrical, Computer, and Systems Engineering, Case Western Reserve University, Cleveland, Ohio., Taylor D; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio; Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio., Miyagi M; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio., Tang W; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio., Feng H; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio., Li Y; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio., Wang Z; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio., Graor H; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Willis J; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio; Department of Pathology, Case Western Reserve University, Cleveland, Ohio., Bryson E; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Department of Pathology, Case Western Reserve University, Cleveland, Ohio., Boutros CS; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Desai O; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Islam B; Department of Medicine, Case Western Reserve University, Cleveland, Ohio; Department of Medicine, Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Ellis LM; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas., Moss SE; Institute of Ophthalmology, University College London, London, UK., Winter JM; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Greenwood J; Institute of Ophthalmology, University College London, London, UK., Wang R; Department of Surgery, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio. Electronic address: RXW517@case.edu.

Publikováno v: Gastroenterology [Gastroenterology] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.